Urgent

Mediastinal mass — evaluation

compartment-based work-up · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Mediastinal masses are evaluated by anatomical compartment (anterior, middle, posterior), which narrows the differential. Priorities are excluding airway/vascular compromise, obtaining tissue safely, and identifying treatable causes such as lymphoma, germ-cell tumour and thymoma.

Red flags

  • Stridor or positional dyspnoea (airway compression)
  • Superior vena cava obstruction (facial swelling, distended veins)
  • Haemodynamic compromise supine
  • Rapidly enlarging mass with systemic symptoms

Assessment

Differential diagnosis

  • Anterior: thymoma, lymphoma, germ-cell tumour, thyroid (the '4 Ts')
  • Middle: lymphadenopathy, bronchogenic cyst, vascular anomaly
  • Posterior: neurogenic tumour
  • Sarcoidosis / reactive lymphadenopathy
  • Metastatic disease

Investigations

  • Contrast CT chest to localise compartment and characterise the mass
  • Tumour markers (AFP, beta-hCG, LDH) for germ-cell tumour/lymphoma
  • MRI for posterior/neurogenic or vascular lesions
  • Tissue sampling (EBUS/core biopsy/mediastinoscopy) as appropriate
  • Assess for superior vena cava obstruction and airway compromise
  • Acetylcholine-receptor antibodies if thymoma/myasthenia suspected

Management

  • Assess urgently for airway compromise and superior vena cava obstruction
  • Localise the mass to a mediastinal compartment on CT
  • Build a compartment-based differential diagnosis
  • Send tumour markers (AFP, beta-hCG, LDH) before biopsy where germ-cell tumour/lymphoma possible
  • Evaluate for myasthenia gravis if an anterior thymic lesion is present
  • Plan the safest, most informative tissue biopsy with MDT input
  • Avoid unnecessary sedation/anaesthesia with a large anterior mass risking airway collapse
  • Treat chemosensitive tumours (lymphoma, germ-cell) medically once diagnosed
  • Refer resectable thymoma/neurogenic tumours for surgery
  • Manage emergencies (SVC obstruction, airway) per dedicated pathways

Drugs & doses

No empirical drug before tissue diagnosis (avoid steroids that can mask lymphoma histology)
Treat confirmed lymphoma/germ-cell tumour with cause-specific chemotherapy
Corticosteroids / SVC stenting for symptomatic superior vena cava obstruction
Manage myasthenia gravis with pyridostigmine/immunotherapy if confirmed

Disposition

Urgent thoracic MDT; airway/SVC emergency pathway if compromised; cause-directed treatment after safe tissue diagnosis.

Complications & pitfalls

  • Airway collapse under anaesthesia (anterior mediastinal mass syndrome)
  • Superior vena cava obstruction
  • Cardiac/great-vessel compression
  • Diagnostic delay for treatable malignancy

Exam pearls

  • Avoid giving corticosteroids before biopsy if lymphoma is possible — they can obscure the histology
  • A large anterior mediastinal mass can collapse the airway under general anaesthesia — plan carefully
  • Measure AFP/beta-hCG before invasive procedures for possible germ-cell tumour
  • Anterior-compartment '4 Ts': thymoma, teratoma/germ-cell, (terrible) lymphoma, thyroid

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.